Pancrelipase lipase

DB13147ApprovedInvestigationalProtein Based TherapiesGastrointestinal Agents

Pancrelipase lipase is a lipase used to treat pancreatic exocrine insufficiency. Pancrelipase, in general, is composed of a mixture of pancreatic enzymes which include amylases, lipases, and proteases.

Protein structure of Pancrelipase lipase
Mechanism
Curator reviewed · 1 reference
Primary indication
Please refer to DB00085.Curator reviewed · 13 structured indications
Formula / weight
48000.0 Da
First approval
Canada, 2011 · United States, 2009
Also known as
Lipase, pancreatic · Pancreatic lipase
Brand names
  • Cotazym
  • Creon
  • Pancrease MT
  • Pancreaze
  • Pertzye
  • Viokace
  • Zenpep

Resolves to

Clinical / RWD

What you can answer from here — as of May 03, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
19Clinical trialsPhase, status and sponsor resolved per trial
Sign in
13Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
131Marketed productsAcross 6 countries and 37 labellers
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Pancrelipase lipase, and which companies have late-stage candidates in those indications?

Create a free account or log in to explore the full data card.

Create Account